Reply
- PMID: 35778779
- PMCID: PMC12094246
- DOI: 10.1002/hep.32645
Reply
Conflict of interest statement
CONFLICT OF INTEREST
Gynogyi Szabo owns stock and consults for Zomagen Bioscience. She owns stock in Glympse and Satellite Bio. She consults for Durect Corp, Cyte, Novartis, Pandion Therapeutics, Surrozen, Terra Firma, Pfizer, Merck, and Evive.
Comment on
- Hepatology.
-
Letter to the editor: Combination treatment with IL-1 antagonist, pentoxifylline and zinc for severe alcoholic hepatitis: Are we there yet?Hepatology. 2022 Nov;76(5):E110-E111. doi: 10.1002/hep.32646. Epub 2022 Jul 12. Hepatology. 2022. PMID: 35776003 No abstract available.
-
Letter to the editor: IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcoholic hepatitis-More questions than answers!Hepatology. 2022 Nov;76(5):E112-E113. doi: 10.1002/hep.32648. Epub 2022 Jul 11. Hepatology. 2022. PMID: 35776666 No abstract available.
References
-
- Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M, Mathurin P, et al.; on behalf of the NIAAA Alcoholic Hepatitis Consortia. Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology. 2016;150:785–90. - PMC - PubMed
-
- McClain CJ, Kirpich IA, Smart L. Chapter 19: malnutrition and liver diseases. In: Schiff ER, Maddrey WC, Sorrell MF, editors. Schiff’s diseases of the liver. 12th ed. Hoboken: Wiley; 2017. p. 460–87.
Grants and funding
- U01 AA026938/AA/NIAAA NIH HHS/United States
- U01AA021890/NH/NIH HHS/United States
- VA HSR&D funding
- R01 AA028190/AA/NIAAA NIH HHS/United States
- 1P50AA024337/NH/NIH HHS/United States
- R21 AR 071046/NH/NIH HHS/United States
- P50 AA024333/AA/NIAAA NIH HHS/United States
- UO1 AA023902/NH/NIH HHS/United States
- UO1 AA026933/NH/NIH HHS/United States
- RO1 DK113196/NH/NIH HHS/United States
- U01 AA021893/AA/NIAAA NIH HHS/United States
- U01 AA021901/AA/NIAAA NIH HHS/United States
- U01 AA026933/AA/NIAAA NIH HHS/United States
- U01AA026938/NH/NIH HHS/United States
- UO1 AA026976/NH/NIH HHS/United States
- R01 GM119174/GM/NIGMS NIH HHS/United States
- UO1 AA021890/NH/NIH HHS/United States
- U01AA021901/NH/NIH HHS/United States
- P50 AA024337/AA/NIAAA NIH HHS/United States
- R21 AR071046/AR/NIAMS NIH HHS/United States
- U01 AA021890/AA/NIAAA NIH HHS/United States
- UH3 AA026970/AA/NIAAA NIH HHS/United States
- P50 AA024333/NH/NIH HHS/United States
- U01 AA026977/AA/NIAAA NIH HHS/United States
- RO1 AA028190/NH/NIH HHS/United States
- U01 AA026976/AA/NIAAA NIH HHS/United States
- UH3 AA026970/NH/NIH HHS/United States
- U01 AA026977/NH/NIH HHS/United States
- UO1 AA026976-03S1/NH/NIH HHS/United States
- RO1 GM119174/NH/NIH HHS/United States
- R01 DK113196/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources